Cannabis Science, Inc.
(Other OTC/NBB : CBIS)

( )
CBIS After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Biotechnology
MRNAModerna, Inc. 14.65%71.780.0%$1188.28m
NVAXNovavax, Inc. 10.56%104.32102.0%$894.13m
AMGNAmgen, Inc. 0.40%250.041.3%$686.39m
REGNRegeneron Pharmaceuticals, Inc. -0.80%615.882.5%$630.55m
GILDGilead Sciences, Inc. 0.47%76.681.0%$625.83m
BIIBBiogen, Inc. -0.85%276.521.6%$592.84m
VXRTVaxart, Inc. 51.88%12.120.0%$534.03m
VRTXVertex Pharmaceuticals, Inc. -3.27%284.821.9%$460.66m
ILMNIllumina, Inc. -0.30%369.133.5%$296.54m
BMRNBioMarin Pharmaceutical, Inc. -1.32%124.404.3%$210.55m
BNTXBioNTech SE 10.55%77.780.0%$206.32m
ALXNAlexion Pharmaceuticals, Inc. -1.65%107.031.9%$204.83m
SGENSeattle Genetics, Inc. -3.31%168.586.1%$186.16m
SRNESorrento Therapeutics, Inc. -4.22%7.721.8%$182.30m
IMMUImmunomedics, Inc. -3.27%39.9711.0%$172.59m

Company Profile

Cannabis Science, Inc. develops cannabis pharmaceutical products. It works on phytocannabinoid science targeting critical illnesses and adheres to scientific methodologies to develop, produce, and commercialize phytocannabinoid-based pharmaceutical products. The company was founded by Raymond C. Dabney on February 29, 1996 and is headquartered in Irvine, CA.